2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with Peritoneal Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Collins, F; Esnal-Zufiaurre, A; Giakoumelou, S; Greaves, E; Horne, AW; Saunders, PT | 1 |
1 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and Peritoneal Diseases
Article | Year |
---|---|
Estrogen receptor (ER) agonists differentially regulate neuroangiogenesis in peritoneal endometriosis via the repellent factor SLIT3.
Topics: Adolescent; Adult; Animals; Cells, Cultured; Embryo, Mammalian; Endometriosis; Endometrium; Estrogens; Female; Humans; Membrane Proteins; Mice; Mice, Inbred C57BL; Middle Aged; Neovascularization, Pathologic; Neurogenesis; Nitriles; Peritoneal Diseases; Phenols; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Young Adult | 2014 |